Plasma lipoproteins during and after danazol treatment
- 11 January 1984
- journal article
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 63 (S123) , 133-135
- https://doi.org/10.3109/00016348409157000
Abstract
Twelve women with pelvic endometriosis were treated with danazol, at a dose of 200 mg three times daily, over a 24‐week period. The concentrations of cholesterol and triglycerides were determined in plasma and in the lipoprotein fractions. After only 2 weeks the mean high density lipoprotein (HDL) cholesterol had already decreased by 49% and 6 weeks later the reduction was 59%. The low density lipoprotein (LDL) cholesterol concentration increased by 14% after 2 weeks and by 34% after 8 weeks. The triglycerides increased by 20% after 2 weeks. Eight weeks after cessation of treatment the lipoprotein fractions had returned to the pretreatment levels.Keywords
This publication has 12 references indexed in Scilit:
- L‐norgestrel and progesterone have different influences on plasma lipoproteinsEuropean Journal of Clinical Investigation, 1983
- Effects of danazol on plasma lipid and lipoprotein levels in healthy women and in women with endometriosisAmerican Journal of Obstetrics and Gynecology, 1983
- HDL3 and HDL2 determination by a combined ultracentrifugation and precipitation procedureClinica Chimica Acta; International Journal of Clinical Chemistry, 1981
- Reduction of plasma high-density lipoprotein2 cholesterol and increase of postheparin plasma hepatic lipase activity during progestin treatmentClinica Chimica Acta; International Journal of Clinical Chemistry, 1981
- Cholesterol, High Density Lipoprotein and DanazolJournal of Clinical Endocrinology & Metabolism, 1981
- Effects of Different Progestogens on Lipoproteins during Postmenopausal Replacement TherapyNew England Journal of Medicine, 1981
- Effects of danazol and lynestrenol on serum lipoproteins in endometriosisClinical Pharmacology & Therapeutics, 1980
- DANAZOL AND CHOLESTEROL METABOLISMThe Lancet, 1979
- Cholesterol in the Prediction of Atherosclerotic DiseaseAnnals of Internal Medicine, 1979
- High density lipoprotein as a protective factor against coronary heart diseaseThe American Journal of Medicine, 1977